In summary, pregnancy zone protein (PZP) was identified as a newfound serum indicator for monitoring CRC in patients with T2DM, which will boost the noninvasive diagnosis rate for CRC in clinical practice. This evidence concerns the gene PZP and type 2 diabetes mellitus.